CNBC: Stock futures edged higher in morning trading Tuesday following a broad-based rally on news that U.S. regulators granted full approval for Pfizer-BioNTech’s Covid vaccine.
Futures on the Dow Jones Industrial Average rose 65 points. S&P 500 futures and Nasdaq 100 futures traded in positive territory.
The market started the week on a high note as shares sensitive to an economic recovery jumped on optimism that the vaccine approval would clear path for more mandates in the face of the spread of the delta variant.
“Considering the recent spike in cases and some of the disappointing economic data, this is another step in the right direction, and it helps give confidence to those who might still be holding out on getting the vaccine,” said Ryan Detrick, chief market strategist at LPL Financial. Read More